Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
25.38
+0.13 (0.51%)
Oct 11, 2024, 4:00 PM EDT - Market closed
Anika Therapeutics Employees
Anika Therapeutics had 357 employees as of December 31, 2023. The number of employees increased by 12 or 3.48% compared to the previous year.
Employees
357
Change (1Y)
12
Growth (1Y)
3.48%
Revenue / Employee
$467,451
Profits / Employee
-$207,782
Market Cap
375.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Enhabit | 10,800 |
Organogenesis Holdings | 862 |
Sage Therapeutics | 487 |
Esperion Therapeutics | 240 |
Butterfly Network | 225 |
Voyager Therapeutics | 162 |
Nyxoah | 147 |
C4 Therapeutics | 145 |
ANIK News
- 9 days ago - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Anika Therapeutics, Inc (ANIK) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Anika Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Anika to Participate in the Sidoti Virtual Investor Conference - GlobeNewsWire
- 2 months ago - Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024 - GlobeNewsWire
- 3 months ago - Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs - GlobeNewsWire
- 3 months ago - Orthopedic Regenerative Surgical Products Market Size to Reach USD 6.6 Billion By 2033, at 4.4 CAGR: Insights by Dimension Market Research - GlobeNewsWire
- 4 months ago - Anika Enters into Cooperation Agreement with Caligan Partners - GlobeNewsWire